Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 7.64% is 125% above its 5-year average of -30.02%, near the high end of its 5-year range (-218.34%–23.24%).
As of the fiscal period ended Tuesday, March 31, 2026. 51.88% below its 12-month average of 15.89%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
7.64%
OPERATING MARGIN AVG TTM
15.89%
OPERATING MARGIN AVG 3Y
9.20%
OPERATING MARGIN AVG 5Y
-20.61%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-51.88%
CURRENT VS 3Y AVG
-16.88%
CURRENT VS 5Y AVG
+137.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.01%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-49.07%
vs the sector median at left
TransMedics Group, Inc.
Market Cap
$2.81B
Operating Margin
7.64%
TTM Avg
15.89%
3Y Avg
9.20%
5Y Avg
-20.61%
Market Cap
$2.83B
Operating Margin
5.87%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.19B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$467.85M
Operating Margin
-57.48%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
Market Cap
$15.31M
Operating Margin
-126.72%
TTM Avg
-136.51%
3Y Avg
-118.68%
5Y Avg
-103.43%
Market Cap
$7.06B
Operating Margin
1.32%
TTM Avg
4.35%
3Y Avg
-1.93%
5Y Avg
-10.04%
Market Cap
$7.92B
Operating Margin
0.08%
TTM Avg
-1.39%
3Y Avg
-5.39%
5Y Avg
-20.02%
Market Cap
$8.15B
Operating Margin
-19.76%
TTM Avg
-59.22%
3Y Avg
-59.52%
5Y Avg
-72.58%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.81B | 7.64% | 15.89% | 9.20% | -20.61% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.83B | 5.87% | -8.16% | -10.59% | -4.68% |
| Teladoc Health, Inc. (TDOC)vs › | $1.19B | -6.98% | -25.06% | -156.73% | -114.38% |
| Shoulder Innovations, Inc. (SI)vs › | $467.85M | -57.48% | -50.96% | -52.76% | -52.76% |
| NRC Health (NRC)vs › | $442.23M | 10.53% | 20.52% | 24.67% | 27.45% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -126.72% | -136.51% | -118.68% | -103.43% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 1.32% | 4.35% | -1.93% | -10.04% |
| Oscar Health, Inc. (OSCR)vs › | $7.92B | 0.08% | -1.39% | -5.39% | -20.02% |
| Tempus AI, Inc. (TEM)vs › | $8.15B | -19.76% | -59.22% | -59.52% | -72.58% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.99B | 9.25% | 10.48% | 12.70% | 14.08% |
Gross Margin
59.1%
Operating Margin
7.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 7.64% |
| 2025-12-31 | 13.23% |
| 2025-09-30 | 16.20% |
| 2025-06-30 | 23.24% |
| 2025-03-31 | 19.12% |
| 2024-12-31 | 7.11% |
| 2024-09-30 | 3.61% |
| 2024-06-30 | 10.94% |
| 2024-03-31 | 12.82% |
| 2023-12-31 | 3.21% |
| 2023-09-30 | -42.65% |
| 2023-06-30 | -1.73% |
| 2023-03-31 | -5.03% |
| 2022-12-31 | -21.61% |
| 2022-09-30 | -21.59% |
| 2022-06-30 | -47.49% |
| 2022-03-31 | -59.00% |
| 2021-12-31 | -117.17% |
| 2021-09-30 | -218.34% |
| 2021-06-30 | -120.77% |
| 2021-03-31 | -92.26% |
| 2020-12-31 | -77.30% |
| 2020-09-30 | -65.01% |
| 2020-06-30 | -231.82% |
| 2020-03-31 | -106.47% |
| 2019-12-31 | -143.54% |
| 2019-09-28 | -100.51% |
| 2019-06-29 | -135.99% |
| 2019-03-30 | -127.50% |
| 2018-12-31 | -179.49% |
| 2018-09-30 | -97.52% |
| 2018-06-30 | -176.88% |
| 2018-03-31 | -189.80% |
| 2017-12-30 | -213.96% |
| 2017-09-30 | -253.29% |
| 2017-07-01 | -255.91% |
| 2017-04-01 | -301.48% |
